Is starting insulin with 10 units of glargine (insulin glargine) and 22 units of bolus (8-8-6) a correct approach, given that it doesn't follow the traditional 50/50 basal to bolus insulin ratio?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is the 10 Units Glargine + 22 Units Bolus (8-8-6) Approach Wrong?

Yes, this approach is fundamentally flawed and violates evidence-based insulin dosing principles. The regimen you describe provides only 31% basal insulin (10 units) versus 69% bolus insulin (22 units), which is the inverse of physiologic insulin requirements and contradicts established guidelines.

Why This Approach Is Problematic

The 50:50 Basal-Bolus Principle

  • The American Diabetes Association explicitly recommends that basal-bolus insulin therapy requires approximately 50% of total daily insulin as basal and 50% as bolus (prandial) insulin for type 1 diabetes. 1
  • For type 2 diabetes patients requiring both basal and prandial coverage, the physiologic distribution should similarly approximate 50:50, though type 2 diabetes may tolerate some variation. 2
  • The fundamental approach emphasizes that basal insulin controls fasting and between-meal glucose, while prandial insulin addresses postprandial excursions—both components require balanced dosing. 2

What the Guidelines Actually Recommend

For insulin initiation in type 2 diabetes:

  • Start with basal insulin alone at 10 units once daily or 0.1-0.2 units/kg/day, NOT with simultaneous basal-bolus therapy. 3
  • Basal insulin should be titrated by 2-4 units every 3 days until fasting blood glucose reaches 80-130 mg/dL. 3
  • Metformin should be continued unless contraindicated. 3

Only advance to basal-bolus when:

  • Basal insulin has been optimally titrated (fasting glucose 80-130 mg/dL) but A1C remains above target after 3-6 months. 3, 1
  • Basal insulin dose approaches 0.5-1.0 units/kg/day without achieving glycemic goals. 3, 1, 2

When Adding Prandial Insulin: The Correct Approach

If basal-bolus therapy is truly indicated, the starting algorithm should be:

  • Start prandial insulin at 4 units per meal, 0.1 units/kg per meal, OR 10% of the basal dose per meal. 3
  • If starting with 10 units of glargine, the initial prandial dose would be approximately 1 unit per meal (10% of basal), NOT 8-8-6 units. 3
  • Consider decreasing the basal insulin dose by the same amount as the starting mealtime dose if A1C is <8%. 3

The Correct 50:50 Distribution

For a patient requiring 32 units total daily dose (as in your example):

  • Basal insulin: 16 units glargine once daily
  • Bolus insulin: 16 units total, divided as approximately 5-5-6 units before meals
  • This maintains the physiologic 50:50 distribution. 1, 2

Critical Threshold: Overbasalization vs. Under-Basalization

The Danger of Excessive Bolus Insulin

  • When bolus insulin dominates the regimen (as in the 10 glargine + 22 bolus example), patients experience:
    • Inadequate fasting glucose control (insufficient basal coverage)
    • Excessive postprandial insulin exposure
    • Increased hypoglycemia risk between meals
    • Poor overnight glucose control 1, 2

Recognizing Overbasalization (The Opposite Problem)

  • Clinical signals of overbasalization include: basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, and high glucose variability. 1, 2
  • When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, add prandial insulin rather than continuing to escalate basal insulin alone. 3, 1, 2

The Correct Algorithmic Approach

Step 1: Start with Basal Insulin Alone

  • Initial dose: 10 units glargine once daily or 0.1-0.2 units/kg/day. 3, 1
  • Continue metformin unless contraindicated. 3
  • Titrate by 2-4 units every 3 days based on fasting glucose. 3

Step 2: Optimize Basal Insulin First

  • Target fasting glucose: 80-130 mg/dL. 3, 1
  • If fasting glucose ≥180 mg/dL, increase by 4 units every 3 days. 1
  • If fasting glucose 140-179 mg/dL, increase by 2 units every 3 days. 1

Step 3: Add Prandial Insulin Only When Indicated

  • Add prandial insulin when basal insulin is optimized but A1C remains elevated after 3-6 months. 3, 1
  • Start with 4 units before the largest meal or 10% of basal dose. 3
  • Maintain approximately 50:50 basal-bolus distribution as you titrate. 1, 2

Step 4: Recalculate and Redistribute

  • When basal insulin is increased, recalculate the total daily dose (TDD) and redistribute bolus insulin to maintain the 50:50 ratio. 2
  • Recalculate insulin sensitivity factor (ISF) using 1500/new TDD. 2
  • Do not continue using the same bolus doses from Day 1 when basal insulin has been escalated. 2

Common Pitfalls to Avoid

  • Never start with simultaneous high-dose basal-bolus therapy in insulin-naive type 2 diabetes patients unless they have severe hyperglycemia (A1C ≥10-12% with symptomatic/catabolic features). 1
  • Do not skip the basal-only optimization phase—this is the foundation of insulin therapy. 3
  • Avoid continuing to use fixed bolus doses without recalculating when basal insulin changes—this violates the physiologic 50:50 principle. 2
  • Do not delay treatment intensification, but also do not over-intensify prematurely. 3, 1

Evidence from Clinical Trials

  • The RABBIT 2 trial demonstrated that basal-bolus insulin therapy (glargine + glulisine) starting at 0.4-0.5 units/kg/day total (split appropriately between basal and bolus) achieved superior glycemic control compared to sliding scale insulin in hospitalized type 2 diabetes patients. 4
  • A Latin American study showed equivalent glycemic control with mean insulin doses of 0.76 units/kg/day (glargine 22 units/day + glulisine 31 units/day), demonstrating approximately 42% basal and 58% bolus distribution in hospitalized patients. 5
  • Recent real-world data from 306 patients with type 2 diabetes followed for 3.4 years challenges the rigid 50:50 rule, showing that three-quarters of patients maintaining stable glycemic control had basal insulin fractions <50%, with half having <41.2% basal. 6

Reconciling Guidelines with Real-World Evidence

While the 2023 real-world study 6 shows variation from 50:50 in established patients, this does NOT justify starting with 31% basal (10 units) and 69% bolus (22 units). The study examined patients after prolonged titration and optimization, not initial dosing strategies. The key principles remain:

  • Start with basal insulin alone in most type 2 diabetes patients. 3
  • When adding prandial insulin, start conservatively (4 units per meal or 10% of basal). 3
  • Allow individualized titration over time to find the optimal basal-bolus distribution for each patient. 6
  • The 50:50 ratio serves as a starting framework, not a rigid endpoint. 6

The approach of starting with 10 units glargine + 22 units bolus (8-8-6) bypasses evidence-based initiation protocols and exposes patients to unnecessary hypoglycemia risk and suboptimal glycemic control.

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Basal Insulin Dose Adjustment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.